The FDA has published new guidance aimed at reducing or stopping toxicity studies of monoclonal antibody-based drugs in non-human primates (NHPs), in the latest stage of an ongoing effort to reduce ...
A slower "reasoning" model might do more of the work for you -- and keep vibe coding from becoming a chore.
Matt Webber is an experienced personal finance writer, researcher, and editor. He has published widely on personal finance, marketing, and the impact of technology on contemporary arts and culture.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback